Sox2 enhances the tumorigenicity and chemoresistance of cancer stem-like cells derived from gastric cancer

Journal of Biomedical Research

Volumn 26, Issue 5, 2012, Pages 336-345

  Tian, Tian ^a   Zhang, Yajie ^a   Wang, Shouyu ^a   Zhou, Jianwei ^a   Xu, Shan ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

CD44; Chemoresistance; Gastric cancer stem like cells; Side population; Sox2

Indexed keywords

CISPLATIN; HERMES ANTIGEN; MESSENGER RNA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SOX2;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CANCER STEM CELL; CARCINOGENICITY; CELL ISOLATION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO DEVELOPMENT; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CANCER; TUMOR VOLUME; WESTERN BLOTTING;

EID: 84870865512     PISSN: 16748301     EISSN: None     Source Type: Journal    
DOI: 10.7555/JBR.26.20120045     Document Type: Article

References (37)

1. Yuasa Y Control of gut differentiation and intestinal-type gastric carcinogenesis. Nat Rev Cancer 2003, 3:592-600.
2. Wu Q, Yang Z, Hu S, Su T, An Y, Zhang Z, et al. Stem Cell Associated Genes Working with One MiRNA Cluster Have Different Clinic Pathologic Values in Gastric Cancer. Pathol Oncol Res 2011, 17:939-946.
3. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, To-daro M, Peschle C, et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007, 445:111-115.
4. O'Brien CA, Pollett A, Gallinger S, Dick JE A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007, 445:106-110.
5. Haraguchi N, Utsunomiya T, Inoue H, Tanaka F, Mimori K, Barnard GF, et al. Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells 2006, 24:506-513.
6. Visvader JE, Lindeman GJ Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 2008, 8:755-768.
7. Zhou J, Wulfkuhle J, Zhang H, Gu P, Yang Y, Deng J, et al. Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proc Natl Acad Sci U S A 2007, 104:16158-16163.
8. Charafe-Jauffret E, Ginestier C, Iovino F, Wicinski J, Cervera N, Finetti P, et al. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res 2009, 69:1302-1313.
9. Dean M, Fojo T, Bates S Tumour stem cells and drug resistance. Nat Rev Cancer 2005, 5:275-284.
10. Bleau AM, Hambardzumyan D, Ozawa T, Fomchenko EI, Huse JT, Brennan CW, et al. PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Cell Stem Cell 2009, 4:226-235.
11. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444:756-760.
12. Wang J, Guo LP, Chen LZ, Zeng YX, Lu SH Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line. Cancer Res 2007, 67:3716-3724.
13. Loebinger MR, Giangreco A, Groot KR, Prichard L, Allen K, Simpson C, et al. Squamous cell cancers contain a side population of stem-like cells that are made chemo-sensitive by ABC transporter blockade. Br J Cancer 2008, 98:380-387.
14. Fukuda K, Saikawa Y, Ohashi M, Kumagai K, Kitajima M, Okano H, et al. Tumor initiating potential of side population cells in human gastric cancer. Int J Oncol 2009, 34:1201-1207.
15. Chen T, Yang K, Yu J, Meng W, Yuan D, Bi F, et al. Identification and expansion of cancer stem cells in tumor tissues and peripheral blood derived from gastric adenocarcinoma patients. Cell Res 2012, 22:248-258.
16. Ohkuma M, Haraguchi N, Ishii H, Mimori K, Tanaka F, Kim HM, et al. Absence of CD71 Transferrin Receptor Characterizes Human Gastric Adenosquamous Carcinoma Stem Cells. Ann Surg Oncol 2012, 19:1357-1364.
17. Han ME, Jeon TY, Hwang SH, Lee YS, Kim HJ, Shim HE, et al. Cancer spheres from gastric cancer patients provide an ideal model system for cancer stem cell research. Cell Mol Life Sci 2011, 68:3589-3605.
18. Jiang J, Zhang Y, Chuai S, Wang Z, Zheng D, Xu F, et al. Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype. Oncogene 2012, 31:671-682.
19. Yang L, Ping YF, Yu X, Qian F, Guo ZJ, Qian C, et al. Gastric cancer stem-like cells possess higher capability of invasion and metastasis in association with a mesenchymal transition phenotype. Cancer Lett 2011, 310:46-52.
20. Hu C, Li H, Li J, Zhu Z, Yin S, Hao X, et al. Analysis of ABCG2 expression and side population identifies intrinsic drug efflux in the HCC cell line MHCC-97L and its modulation by Akt signaling. Carcinogenesis 2008, 29:2289-2297.
21. Xu YQ, Li AP, Chen R, Zhou JW [The role of JWA in N-methyl-N'-nitro-N-nitrosoguanidine induced human bronchial epithelial cell apoptosis]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2006, 24:205-208.
22. Avilion AA, Nicolis SK, Pevny LH, Perez L, Vivian N, Lovell-Badge R Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev 2003, 17:126-140.
23. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005, 122:947-956.
24. Zheng Q, Gong F, Xu Y, Zheng T, Ying M Floating cells with stem cell properties in gastric cell line SGC-7901. Tumori 2011, 97:393-399.
25. Scharenberg CW, Harkey MA, Torok-Storb B The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 2002, 99:507-512.
26. Zhou S, Schuetz JD, Bunting KD, Colapietro AM, Sam-path J, Morris JJ, et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 2001, 7:1028-1034.
27. + and ABCG2-cancer cells are similarly tumorigenic. Cancer Res 2005, 65:6207-6219.
28. Hirschmann-Jax C, Foster AE, Wulf GG, Nuchtern JG, Jax TW, Gobel U, et al. A distinct " side population" of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci U S A 2004, 101:14228-14233.
29. Bunting KD, Zhou S, Lu T, Sorrentino BP Enforced P-glycoprotein pump function in murine bone marrow cells results in expansion of side population stem cells in vitro and repopulating cells in vivo. Blood 2000, 96:902-909.
30. Sholl LM, Long KB, Hornick JL Sox2 expression in pulmonary non-small cell and neuroendocrine carcinomas. Appl Immunohistochem Mol Morphol 2010, 18:55-61.
31. Ellis P, Fagan BM, Magness ST, Hutton S, Taranova O, Hayashi S, et al. SOX2, a persistent marker for multipotential neural stem cells derived from embryonic stem cells, the embryo or the adult. Dev Neurosci 2004, 26:148-165.
32. Gangemi RM, Griffero F, Marubbi D, Perera M, Capra MC, Malatesta P, et al. SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity. Stem Cells 2009, 27:40-48.
33. Lee C, Fotovati A, Triscott J, Chen J, Venugopal C, Singhal A, et al. Polo-Like Kinase 1 (PLK1) Inhibition Kills Glioblastoma Multiforme Brain Tumour Cells in Part Through Loss of SOX2 and Delays Tumour Progression in Mice. Stem Cells 2012 Mar 13, [Epub ahead of print]. 10.1002/stem.1081.
34. Xiang R, Liao D, Cheng T, Zhou H, Shi Q, Chuang TS, et al. Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer. Br J Cancer 2011, 104:1410-1417.
35. Nishii T, Yashiro M, Shinto O, Sawada T, Ohira M, Hirakawa K Cancer stem cell-like SP cells have a high adhesion ability to the peritoneum in gastric carcinoma. Cancer Sci 2009, 100:1397-1402.
36. Otsubo T, Akiyama Y, Yanagihara K, Yuasa Y SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis. Br J Cancer 2008, 98:824-831.
37. Matsuoka J, Yashiro M, Sakurai K, Kubo N, Tanaka H, Muguruma K, et al. Role of the Stemness Factors Sox2, Oct3/4, and Nanog in Gastric Carcinoma. J Surg Res 2012, 174:130-135.